ArticleGeburtshilfe und Frauenheilkunde2026
Consequences of Maternal Antidepressant and Anticonvulsant Use During Pregnancy: Is Postnatal Inpatient Monitoring Required? - A Retrospective Cohort Study.
Article in Geburtshilfe und Frauenheilkunde, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Prenatal exposure to antidepressants and anticonvulsants is steadily increasing in parallel with rising prescription rates. Our study focused on potential postnatal adjustment disorders in newborns and their appropriate monitoring after birth. Objective: To descriptively assess clinically relevant complications in neonates after intrauterine exposure to antidepressants and/or anticonvulsants and to evaluate the need for routine postnatal monitoring. Methods: We conducted a retrospective single-center cohort study at the University Hospital Erlangen (01/2021-12/2023). The study included 120 neonates whose mothers received antidepressants, anticonvulsants, or both during pregnancy. The primary endpoint was a clinically relevant respiratory event (apnea, dyspnea/desaturation, or need for ventilatory support). An exploratory multivariable logistic regression with the primary endpoint as the outcome was performed (main analysis: gestational age, maternal age, cesarean delivery; sensitivity analysis additionally including exposure group). Results: The primary endpoint occurred in 31/120 neonates (25.8%). In the main multivariable analysis, gestational age, maternal age, and cesarean delivery showed no statistically significant association with the primary endpoint; in a sensitivity analysis additionally including exposure group, no significant between-group differences were observed. Numeric time-to-event data were available for 22 respiratory events (median 32.5 h; mean 42.0 h); 16/22 (72.7%) occurred within 48 h and 6/22 (27.3%) after 48 h. Hypoglycemia was documented in 15/120 neonates (12.5%) without significant differences between exposure groups. Conclusion: Clinically relevant respiratory events were observed in this monitored cohort of exposed neonates. An initial monitoring period of at least 48 h appears to represent a pragmatic minimum standard. In the presence of clinical abnormalities, risk-adapted prolonged monitoring may be appropriate.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.